Presentation is loading. Please wait.

Presentation is loading. Please wait.

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis  Brian Nolan, MD,

Published byGabriele Boscolo Modified over 5 years ago

Similar presentations

Presentation on theme: "The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis  Brian Nolan, MD,"— Presentation transcript:

1 The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis  Brian Nolan, MD, Samuel Finlayson, MD, MPH, Anna Tosteson, ScD, Richard Powell, MD, Jack Cronenwett, MD  Journal of Vascular Surgery  Volume 45, Issue 6, Pages (June 2007) DOI: /j.jvs Copyright © 2007 The Society for Vascular Surgery Terms and Conditions

2 Fig 1 Trans-Atlantic Inter-Societal Classification (TASC) of femoro-popliteal occlusive disease.8 Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2007 The Society for Vascular Surgery Terms and Conditions

3 Fig 2 Multi-state transition model (Markov process) for treatment of intermittent claudication in patients with SFA occlusive disease. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2007 The Society for Vascular Surgery Terms and Conditions

4 Fig 3 Five year GSVB primary patency and corresponding PTA/S 5-year primary patency threshold for TASC C SFA lesions. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2007 The Society for Vascular Surgery Terms and Conditions

Download ppt "The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis  Brian Nolan, MD,"

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.
A patient with multiple paradoxical emboli

A patient with multiple paradoxical emboli
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Bryan C. Morse, MD, David L. Cull, MD, Corey Kalbaugh, MS, Anna L

Bryan C. Morse, MD, David L. Cull, MD, Corey Kalbaugh, MS, Anna L
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and.

Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and.
Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.
Daniel B. Walsh, MD, Richard J. Powell, MD, Therese A. Stukel, PhD, E

Daniel B. Walsh, MD, Richard J. Powell, MD, Therese A. Stukel, PhD, E
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and.

Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and.
Stenting of femoropopliteal lesions using interwoven nitinol stents

Stenting of femoropopliteal lesions using interwoven nitinol stents
Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score  Daniel M. Ihnat,

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score  Daniel M. Ihnat,
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,

Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,
Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.
Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions  Wei Ye, MD, Chang-Wei Liu,

Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions  Wei Ye, MD, Chang-Wei Liu,
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr

Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr
Adjunctive use of the superficial femoral vein for vascular reconstructions  Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Adjunctive use of the superficial femoral vein for vascular reconstructions  Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,
Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 

Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 

Similar presentations

Ads by Google